Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3274976
Max Phase: Preclinical
Molecular Formula: C15H18N2O5
Molecular Weight: 216.28
Molecule Type: Small molecule
Associated Items:
ID: ALA3274976
Max Phase: Preclinical
Molecular Formula: C15H18N2O5
Molecular Weight: 216.28
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N1CC2(CCNC2)c2ccccc21.O=C(O)C(=O)O
Standard InChI: InChI=1S/C13H16N2O.C2H2O4/c1-10(16)15-9-13(6-7-14-8-13)11-4-2-3-5-12(11)15;3-1(4)2(5)6/h2-5,14H,6-9H2,1H3;(H,3,4)(H,5,6)
Standard InChI Key: ANLBRGQXHINDAJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 216.28 | Molecular Weight (Monoisotopic): 216.1263 | AlogP: 1.28 | #Rotatable Bonds: 0 |
Polar Surface Area: 32.34 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.46 | CX LogP: 0.43 | CX LogD: -2.41 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.71 | Np Likeness Score: 0.22 |
1. Hershenson FM, Prodan KA, Kochman RL, Bloss JL, Mackerer CR.. (1977) Synthesis of beta-spiro[pyrrolidinoindolines], their binding to the glycine receptor, and in vivo biological acitivity., 20 (11): [PMID:199727] [10.1021/jm00221a016] |
Source(1):